BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, December 31, 2025
Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
Inflammatory RSS Feed RSS

Integrin model.
Drug Design, Drug Delivery & Technologies

Innovative design of integrin inhibitors stabilizing its closed conformation

Oct. 7, 2022
Failure of integrin inhibitors in clinical trials can be avoided by redesigning the chemical conformation of these proteins, as shown by a study led by Timothy Springer, a professor in the Department of Biological Chemistry and Molecular Pharmacology at Boston Children's Hospital, and one of the winners of the 2022 Albert Lasker Basic Medical Research Award.
Read More
Skin irritation on hands
Dermatologic

β-Defensin-3 ameliorates atopic dermatitis-associated inflammation by increasing autophagy activation

Oct. 5, 2022
Atopic dermatitis is the most common inflammatory skin disorder with a complex etiology. On the other hand, autophagy is an essential process by which cells break down undesired components to maintain their homeostasis.
Read More
3D illustration of knee joint

Top-line results suggest Paradigm’s injectable Zilosul could be disease-modifying in osteoarthritis

Oct. 4, 2022
By Tamra Sami
Paradigm Biopharmaceuticals Ltd. reported top-line data from its phase II trial of Zilosul (pentosan polysulfate/PPS) that suggest the non-opioid treatment for knee osteoarthritis is effective in navigating pain management but also has the potential to be disease modifying.
Read More
Inflammatory

Biomedcode Hellas patents new compounds for inflammatory disorders

Oct. 4, 2022
Biomedcode Hellas SA has synthesized carboxamide derivatives reported to be useful for the treatment of inflammatory disorders.
Read More
Neural network
Neurology/Psychiatric

AC-0027838 shows analgesic and anti-inflammatory activity in preclinical model

Sep. 27, 2022
Researchers from Alzecure Pharma AB have presented preclinical data on a novel TrkA negative allosteric modulator (NAM), AC-0027838, for...
Read More
Inflammatory

Guangzhou Medical University reports discovery of oral proteasome inhibitor that blocks NLRP3 inflammasome activation

Sep. 19, 2022
Researchers from Guangzhou Medical University (GMU) described the discovery of a novel proteasome inhibitor NIC-0102, being developed as an anti-inflammatory therapeutic candidate.
Read More
Microscopic image of cytoskeletons.
Inflammatory

Cytoskeletal deformations raise antiviral alarm

Sep. 19, 2022
By Anette Breindl
Pathogen-associated molecular patterns (PAMPs) are by themselves not enough to set off a full innate immune response to viral infection. Instead, structural changes to the actin cytoskeleton primed the activation of RIG-I-like receptors (RLRs), a family of intracellular RNA sensors that detect many types of viral RNA. When primed RLRs then encountered viral RNA, they set off an innate immune response that led to the production of interferons.
Read More
Scientist, microscope and dropper
Inflammatory

Delivery of engineered Tregs with tunable IL-2 signaling support enhances Treg potency and survival

Sep. 15, 2022
Gentibio Inc. has announced preclinical data relating to the company's platform technology, demonstrating technical progress to engineer regulatory T cells (Tregs) for the prevention and treatment of autoimmune diseases.
Read More
Musculoskeletal

Domainex nominates DMXD-011 as preclinical drug candidate for interferonopathies

Sep. 15, 2022
Following a research program to identify inhibitors of protein kinases TBK1 and IKK-ε, Domainex Ltd. has nominated DMXD-011 as a preclinical drug candidate.
Read More
ESMO 2022

Study gives new insights into pollution, inflammation, cancer initiation

Sep. 12, 2022
By Anette Breindl
“The association between air pollution and lung cancer is not new,” Charles Swanton told the audience at the European Society of Medical Oncology (ESMO) 2022 Congress. But as with so many associations, causation has been hard to establish, partly due to the puzzling absence of mutations.
Read More
Previous 1 2 … 60 61 62 63 64 65 66 67 68 … 112 113 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Dec. 30, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Dec. 30, 2025.
  • Illustration of magnifying glass looking at cancer in the brain

    Researchers discover how glioblastoma tumors dodge chemotherapy

    BioWorld MedTech
    Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
  • Businessman, businesswoman handshake

    Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact

    BioWorld
    Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
  • Asia focused map inside light bulb

    Big pharma taps fast Asia innovation in search of next Keytruda

    BioWorld
    Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing